[Immune response of Hansen's disease. Review].

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Investigación Clínica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 20306725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Theoretical Basis for the Activity of Thalidomide

  2012cited by this paper
• Mycobacterium bovis BCG Toll-like receptors 2 and 4 cooperation increases the innate epithelial immune response.

  2008cited by this paper
• Antigen-Specific T-Cell Responses of Leprosy Patients

  2008cited by this paper
• Scavenging of reactive nitrogen species by mycobacterial truncated hemoglobins.

  2008cited by this paper
• The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface.

  2008cited by this paper
• Mannan Chain Length Controls Lipoglycans Signaling via and Binding to TLR21

  2008cited by this paper
• Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population.

  2008cited by this paper
• Selection of Antigens and Development of Prototype Tests for Point-of-Care Leprosy Diagnosis

  2008cited by this paper
• "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages.

  2008cited by this paper
• Use of Protein Antigens for Early Serological Diagnosis of Leprosy

  2007cited by this paper
• Mycobacterial Lipomannan Induces Granuloma Macrophage Fusion via a TLR2-Dependent, ADAM9- and β1 Integrin-Mediated Pathway1

  2007cited by this paper
• The role of thalidomide in the management of erythema nodosum leprosum.

  2007cited by this paper
• Functional characterization of a T‐cell receptor BV6+ T‐cell clone derived from a leprosy lesion

  2007cited by this paper
• Increased Langerhans cell accumulation after mycobacterial stimuli

  2007cited by this paper
• Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.

  2007cited by this paper
• TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells

  2005cited by this paper
• Study of apoptosis in skin lesions of leprosy in relation to treatment and lepra reactions.

  2005cited by this paper
• Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells.

  2004cited by this paper
• Differential production of interleukin‐10 and interleukin‐12 in mononuclear cells from leprosy patients with a Toll‐like receptor 2 mutation

  2004cited by this paper
• TUNEL and limited immunophenotypic analyses of apoptosis in paucibacillary and multibacillary leprosy lesions.

  2004cited by this paper
• Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens.

  2003cited by this paper
• Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function

  2003cited by this paper
• Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor‐α

  2003cited by this paper
• Alternate Class I MHC Antigen Processing Is Inhibited by Toll-Like Receptor Signaling Pathogen-Associated Molecular Patterns: Mycobacterium tuberculosis 19-kDa Lipoprotein, CpG DNA, and Lipopolysaccharide1

  2003cited by this paper
• Cutting Edge: A Toll-Like Receptor 2 Polymorphism That Is Associated with Lepromatous Leprosy Is Unable to Mediate Mycobacterial Signaling1

  2003cited by this paper
• Mycobacterium leprae Infection in Monocyte-Derived Dendritic Cells and Its Influence on Antigen-Presenting Function

  2002cited by this paper
• Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy.

  2002cited by this paper
• A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy.

  2002cited by this paper
• Expression of inducible nitric oxide synthase and nitrotyrosine in borderline leprosy lesions

  2001cited by this paper
• A major susceptibility locus for leprosy in India maps to chromosome 10p13

  2001cited by this paper
• T-cell release of granulysin contributes to host defense in leprosy

  2001cited by this paper
• Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients.

  2001cited by this paper
• Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor1

  2001cited by this paper
• Interaction of dendritic cells with mycobacteria: Where the action starts

  2000cited by this paper
• Production of transforming growth factor‐beta 1 (TGF‐β1) by blood monocytes from patients with different clinical forms of leprosy

  2000cited by this paper
• The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.

  2000cited by this paper
• Roles of tumour necrosis factor‐alpha (TNF‐α), transforming growth factor‐beta (TGF‐β), and IL‐10 in the modulation of intercellular adhesion molecule‐1 (ICAM‐1) expression by macrophages during mycobacterial infection

  2000cited by this paper
• Soluble Tumor Necrosis Factor Alpha Receptors in Sera from Leprosy Patients

  1999cited by this paper
• Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

  1999cited by this paper
• Association of vitamin D receptor genotype with leprosy type.

  1999cited by this paper
• Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

  1999cited by this paper
• Spontaneous apoptosis in peripheral blood mononuclear cells of leprosy patients: role of cytokines.

  1999cited by this paper
• The Mannose Receptor Mediates Uptake of Pathogenic and Nonpathogenic Mycobacteria and Bypasses Bactericidal Responses in Human Macrophages

  1999cited by this paper
• IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection.

  1999cited by this paper
• Inducible nitric oxide synthase in human diseases

  1998cited by this paper
• The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules.

  1997cited by this paper
• A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).

  1997cited by this paper
• IL-15, an immunomodulator of T cell responses in intracellular infection.

  1997cited by this paper
• Differential ability of T cell subsets to undergo activation-induced cell death.

  1997cited by this paper
• Transporter associated with antigen-processing (TAP) genes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis.

  1997cited by this paper
• Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy.

  1997cited by this paper
• Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.

  1996cited by this paper
• Induction of Th1 cytokine responses by mycobacterial antigens in leprosy

  1996cited by this paper
• IL-12 regulates T helper type 1 cytokine responses in human infectious disease.

  1994cited by this paper
• A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.

  1994cited by this paper
• Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.

  1993cited by this paper
• Cytokine patterns of immunologically mediated tissue damage.

  1992cited by this paper
• Two TNF receptors.

  1992cited by this paper
• Tumor necrosis factor production in patients with leprosy

  1992cited by this paper
• Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

  1992cited by this paper
• Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes

  1991cited by this paper
• Identification, sequencing, and expression of Mycobacterium leprae superoxide dismutase, a major antigen

  1990cited by this paper
• Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha.

  1990cited by this paper
• Microbial glycolipids: possible virulence factors that scavenge oxygen radicals.

  1989cited by this paper
• Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization

  1989cited by this paper
• Learning from lesions: patterns of tissue inflammation in leprosy.

  1988cited by this paper
• Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

  1988cited by this paper
• Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

  1988cited by this paper
• Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.

  1987cited by this paper
• HLA class II immune response and suppression genes in leprosy.

  1987cited by this paper
• Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

  1987cited by this paper
• Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.

  1986cited by this paper
• HLA-linked control of predisposition to lepromatous leprosy.

  1985cited by this paper
• Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid

  1984cited by this paper
• Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

  1983cited by this paper
• T lymphocyte subsets in the skin lesions of patients with leprosy.

  1983cited by this paper

• [Leprosy reactions in a Colombian national reference centre].

  2013cites this paper
• UVB susceptibility as a risk factor to the development of lepromatous leprosy.

  2010cites this paper